Channels

Sticky Video Player with Ad Breaks
📺 WATCH US NOW!

TrumpRx makes more drug pricing moves and strikes a deal with AstraZeneca

  • Trump announces AstraZeneca deal for lower drug prices on TrumpRx.com platform.
  • AstraZeneca, a UK-based firm, said it will offer discounts on its prescription drug catalog.
  • The deal follows a similar agreement with Pfizer.

President Donald Trump is moving fast with his direct-to-customer pharmaceutical venture.

On Friday, he shared from the Oval Office that he struck a deal with AstraZeneca to offer the US a “most-favored-nation” drug pricing policy that would lower prescription costs.

As part of the deal, AstraZeneca has pledged to invest $50 billion in the US over the next five years in research and development of new drugs and onshore manufacturing. The company has also committed to offering prices to Medicaid patients that are comparable to the lowest prices charged in other countries.

In September, Trump announced TrumpRx.com, a federal government website aimed at making drugs more affordable by eliminating intermediary companies.

“AstraZeneca, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalogue of prescription drugs,” said Trump during a press conference on Friday afternoon.

“You’re gonna pay whatever the lowest pricing in the world there is, that’s what you’re gonna be paying,” Trump added.

AstraZeneca is a British-Swedish pharmaceutical company headquartered in the UK. Some of its key products include the cancer drug Tagrisso and the diabetes medication Farxiga.

In September, a similar deal was announced with Pfizer, for the company to offer some of its drugs on TrumpRx and all of its drugs for Medicaid at a reduced rate, in exchange for a three-year tariff exemption.

The deal comes as the government shutdown enters its 10th day, as Republicans and Democrats remain in a deadlock over extending enhanced premium subsidies for the Affordable Care Act, which is a Biden-era subsidy set to expire at the end of the year.

The Republicans’ proposed budget would pull funding from these subsidies and raise health insurance premiums. According to the Kaiser Family Foundation for health policy research, a dozen states would see their premiums at least double without subsidies, including Mississippi, Wyoming, and Texas.

Read the original article on Business Insider

Content Accuracy: Keewee.News provides news, lifestyle, and cultural content for informational purposes only. Some content is generated or assisted by AI and may contain inaccuracies, errors, or omissions. Readers are responsible for verifying the information. Third-Party Content: We aggregate articles, images, and videos from external sources. All rights to third-party content remain with their respective owners. Keewee.News does not claim ownership or responsibility for third-party materials. Affiliate Advertising: Some content may include affiliate links or sponsored placements. We may earn commissions from purchases made through these links, but we do not guarantee product claims. Age Restrictions: Our content is intended for viewers 21 years and older where applicable. Viewer discretion is advised. Limitation of Liability: By using Keewee.News, you agree that we are not liable for any losses, damages, or claims arising from the content, including AI-generated or third-party material. DMCA & Copyright: If you believe your copyrighted work has been used without permission, contact us at dcma@keewee.news. No Mass Arbitration: Users agree that any disputes will not involve mass or class arbitration; all claims must be individual.

Sponsored Advertisement